Antisense modulation of PTP1B expression

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8853178
SERIAL NO

13177462

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Compounds, compositions and methods are provided for modulating the expression of PTP1B. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding PTP1B. Methods of using these compounds for modulation of PTP1B expression and for treatment of diseases associated with expression of PTP1B are provided.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ISIS PHARMACEUTICALS INCCALIFORNIA USA

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bhanot, Sanjay Carlsbad, US 116 1865
Butler, Madelline M Rancho Santa Fe, US 3 71
Cowsert, Lex M New Braunfels, US 219 3636
Dobie, Kenneth W Del Mar, US 319 3223
Freier, Susan M San Diego, US 526 6555
McKay, Robert Poway, US 102 2107
Monia, Brett P Encinitas, US 303 5836
Wyatt, Jacqueline R Sundance, US 43 1456

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Apr 7, 2026
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00